Structural connectivity predicts clinical outcomes of deep brain stimulation for Tourette syndrome.


Journal

Brain : a journal of neurology
ISSN: 1460-2156
Titre abrégé: Brain
Pays: England
ID NLM: 0372537

Informations de publication

Date de publication:
01 08 2020
Historique:
received: 25 10 2019
revised: 12 03 2020
accepted: 20 04 2020
pubmed: 13 7 2020
medline: 31 12 2020
entrez: 13 7 2020
Statut: ppublish

Résumé

Deep brain stimulation may be an effective therapy for select cases of severe, treatment-refractory Tourette syndrome; however, patient responses are variable, and there are no reliable methods to predict clinical outcomes. The objectives of this retrospective study were to identify the stimulation-dependent structural networks associated with improvements in tics and comorbid obsessive-compulsive behaviour, compare the networks across surgical targets, and determine if connectivity could be used to predict clinical outcomes. Volumes of tissue activated for a large multisite cohort of patients (n = 66) implanted bilaterally in globus pallidus internus (n = 34) or centromedial thalamus (n = 32) were used to generate probabilistic tractography to form a normative structural connectome. The tractography maps were used to identify networks that were correlated with improvement in tics or comorbid obsessive-compulsive behaviour and to predict clinical outcomes across the cohort. The correlated networks were then used to generate 'reverse' tractography to parcellate the total volume of stimulation across all patients to identify local regions to target or avoid. The results showed that for globus pallidus internus, connectivity to limbic networks, associative networks, caudate, thalamus, and cerebellum was positively correlated with improvement in tics; the model predicted clinical improvement scores (P = 0.003) and was robust to cross-validation. Regions near the anteromedial pallidum exhibited higher connectivity to the positively correlated networks than posteroventral pallidum, and volume of tissue activated overlap with this map was significantly correlated with tic improvement (P < 0.017). For centromedial thalamus, connectivity to sensorimotor networks, parietal-temporal-occipital networks, putamen, and cerebellum was positively correlated with tic improvement; the model predicted clinical improvement scores (P = 0.012) and was robust to cross-validation. Regions in the anterior/lateral centromedial thalamus exhibited higher connectivity to the positively correlated networks, but volume of tissue activated overlap with this map did not predict improvement (P > 0.23). For obsessive-compulsive behaviour, both targets showed that connectivity to the prefrontal cortex, orbitofrontal cortex, and cingulate cortex was positively correlated with improvement; however, only the centromedial thalamus maps predicted clinical outcomes across the cohort (P = 0.034), but the model was not robust to cross-validation. Collectively, the results demonstrate that the structural connectivity of the site of stimulation are likely important for mediating symptom improvement, and the networks involved in tic improvement may differ across surgical targets. These networks provide important insight on potential mechanisms and could be used to guide lead placement and stimulation parameter selection, as well as refine targets for neuromodulation therapies for Tourette syndrome.

Identifiants

pubmed: 32653920
pii: 5870430
doi: 10.1093/brain/awaa188
pmc: PMC7447520
doi:

Types de publication

Journal Article Research Support, N.I.H., Extramural Research Support, Non-U.S. Gov't Research Support, U.S. Gov't, Non-P.H.S.

Langues

eng

Sous-ensembles de citation

IM

Pagination

2607-2623

Subventions

Organisme : NCRR NIH HHS
ID : UL1 RR025764
Pays : United States
Organisme : NINDS NIH HHS
ID : R01 NS096008
Pays : United States
Organisme : NIMH NIH HHS
ID : U54 MH091657
Pays : United States
Organisme : NIGMS NIH HHS
ID : P41 GM103545
Pays : United States
Organisme : NCATS NIH HHS
ID : UL1 TR000105
Pays : United States
Organisme : NINR NIH HHS
ID : R01 NR014852
Pays : United States

Informations de copyright

© The Author(s) (2020). Published by Oxford University Press on behalf of the Guarantors of Brain. All rights reserved. For permissions, please email: journals.permissions@oup.com.

Références

Brain. 2010 Dec;133(Pt 12):3649-60
pubmed: 20959309
J Neural Eng. 2019 Feb;16(1):016026
pubmed: 30275348
Brain. 2010 Dec;133(Pt 12):3661-75
pubmed: 21071387
Lancet. 2002 Nov 16;360(9345):1577-86
pubmed: 12443611
Neuroimage Clin. 2018 Feb 21;18:502-509
pubmed: 29560306
Front Neurosci. 2012 Dec 05;6:171
pubmed: 23227001
BMC Neurosci. 2014 Jan 07;15:6
pubmed: 24397347
J Neurol Sci. 2019 Jul 15;402:48-51
pubmed: 31103958
Clin Neurophysiol. 2006 Feb;117(2):447-54
pubmed: 16376143
Arch Gen Psychiatry. 1998 Apr;55(4):326-33
pubmed: 9554428
Curr Biol. 2016 Oct 24;26(20):R1088-R1100
pubmed: 27780050
JAMA Neurol. 2018 Mar 1;75(3):353-359
pubmed: 29340590
Brain. 2011 Mar;134(Pt 3):832-44
pubmed: 21354977
Front Neurosci. 2016 Jan 19;9:519
pubmed: 26834544
World J Biol Psychiatry. 2014 Jan;15(1):66-75
pubmed: 24304122
Radiology. 2019 Oct;293(1):174-183
pubmed: 31385756
J Child Neurol. 2013 May;28(5):615-24
pubmed: 22859696
Ann Neurol. 2017 Jul;82(1):67-78
pubmed: 28586141
Magn Reson Imaging. 2012 Nov;30(9):1323-41
pubmed: 22770690
Brain. 2019 Oct 1;142(10):3086-3098
pubmed: 31377766
J Neural Eng. 2018 Apr;15(2):026005
pubmed: 29235446
Lancet. 1999 Feb 27;353(9154):724
pubmed: 10073521
IEEE Trans Biomed Eng. 1986 Oct;33(10):974-7
pubmed: 3770787
Neuroimage. 2018 Apr 15;170:271-282
pubmed: 28536045
Lancet Neurol. 2017 Aug;16(8):610-619
pubmed: 28645853
Front Integr Neurosci. 2012 Jun 14;6:29
pubmed: 22712007
Brain Stimul. 2016 Mar-Apr;9(2):296-304
pubmed: 26827109
Pediatr Neurol. 2001 Sep;25(3):190-8
pubmed: 11587872
Mayo Clin Proc. 2014 Nov;89(11):1506-14
pubmed: 25444487
Nat Neurosci. 2013 Apr;16(4):386-7
pubmed: 23434914
Arch Gen Psychiatry. 1989 Nov;46(11):1006-11
pubmed: 2684084
J Neural Eng. 2017 Feb;14(1):016014
pubmed: 28068291
Biol Psychiatry. 2019 May 1;85(9):735-743
pubmed: 30777287
J Neural Eng. 2019 Oct 29;16(6):066024
pubmed: 31426036
J Neurosci. 2013 Apr 10;33(15):6581-93
pubmed: 23575855
Neuroimage. 2013 Oct 15;80:105-24
pubmed: 23668970
Neuroreport. 2012 Mar 7;23(4):206-10
pubmed: 22198687
Neuroimage. 2013 Oct 15;80:62-79
pubmed: 23684880
Brain Stimul. 2015 May-Jun;8(3):574-81
pubmed: 25912296
Lancet Neurol. 2015 Jun;14(6):595-605
pubmed: 25882029
Front Hum Neurosci. 2014 May 28;8:362
pubmed: 24904391
Brain Stimul. 2018 Jan - Feb;11(1):158-165
pubmed: 28927961
Neuroimage. 2007 Jan 15;34(2):661-70
pubmed: 17113789
J Neurol Neurosurg Psychiatry. 2020 May;91(5):533-539
pubmed: 32139653
Neurosurgery. 2016 Jan;78(1):91-100
pubmed: 26348012
Neuroimage. 2007 Jan 1;34(1):144-55
pubmed: 17070705
Brain. 2015 Feb;138(Pt 2):472-82
pubmed: 25392196
Neuroscience. 1999 Mar;89(2):335-46
pubmed: 10077317
Brain. 2006 Aug;129(Pt 8):2029-37
pubmed: 16520330
J Neurophysiol. 2015 Jul;114(1):6-20
pubmed: 25925326
Mov Disord Clin Pract. 2018 Oct 03;5(5):499-505
pubmed: 30515438
J Neurosurg. 2007 Nov;107(5):1004-14
pubmed: 17977274
J Neural Eng. 2019 Nov 06;16(6):064002
pubmed: 31344689
Neuroimage. 2011 Feb 1;54(3):2096-104
pubmed: 20974269
JAMA Psychiatry. 2015 Apr;72(4):325-33
pubmed: 25671412
Med Image Anal. 2008 Feb;12(1):26-41
pubmed: 17659998
J Neurol Neurosurg Psychiatry. 2019 Oct;90(10):1078-1090
pubmed: 31129620
J Child Psychol Psychiatry. 1997 Jan;38(1):119-42
pubmed: 9232461
World J Biol Psychiatry. 2009;10(4 Pt 2):567-70
pubmed: 18609432
Neuroimage Clin. 2016 Jun 25;12:165-72
pubmed: 27419067
J Am Acad Child Adolesc Psychiatry. 1989 Jul;28(4):566-73
pubmed: 2768151
Brain Stimul. 2013 Sep;6(5):737-9
pubmed: 23602025
Mov Disord. 2011 Aug 15;26(10):1922-30
pubmed: 21538528
Biol Psychiatry. 2016 Mar 1;79(5):392-401
pubmed: 25034948
Mov Disord. 2017 Oct;32(10):1371-1375
pubmed: 28843016
Ann Neurol. 2010 Apr;67(4):479-87
pubmed: 20437583
Front Psychiatry. 2016 Jul 05;7:118
pubmed: 27458389
Mov Disord. 2015 Aug;30(9):1190-7
pubmed: 25855089
Neuroimage. 2015 Feb 15;107:127-135
pubmed: 25498389
J Psychiatr Res. 2013 Aug;47(8):999-1006
pubmed: 23615189
Cereb Cortex. 2016 Aug;26(8):3508-26
pubmed: 27230218
Brain. 2009 Mar;132(Pt 3):765-77
pubmed: 19136548
Mov Disord. 2019 Apr;34(4):586-588
pubmed: 30788865
Neuroimage. 2012 Aug 15;62(2):774-81
pubmed: 22248573
BMC Neurosci. 2009 May 12;10:47
pubmed: 19435502
Neuropsychologia. 2014 Dec;65:297-301
pubmed: 25128587

Auteurs

Kara A Johnson (KA)

Scientific Computing and Imaging Institute, University of Utah, Salt Lake City, Utah, USA.
Department of Biomedical Engineering, University of Utah, Salt Lake City, Utah, USA.

Gordon Duffley (G)

Scientific Computing and Imaging Institute, University of Utah, Salt Lake City, Utah, USA.
Department of Biomedical Engineering, University of Utah, Salt Lake City, Utah, USA.

Daria Nesterovich Anderson (DN)

Scientific Computing and Imaging Institute, University of Utah, Salt Lake City, Utah, USA.
Department of Biomedical Engineering, University of Utah, Salt Lake City, Utah, USA.
Department of Neurosurgery, University of Utah, Salt Lake City, Utah, USA.

Jill L Ostrem (JL)

Department of Neurology, University of California San Francisco, San Francisco, California, USA.

Marie-Laure Welter (ML)

Institut du Cerveau et de la Moelle Epiniere, Sorbonne Universités, University of Pierre and Marie Curie University of Paris, the French National Institute of Health and Medical Research U 1127, the National Center for Scientific Research 7225, Paris, France.

Juan Carlos Baldermann (JC)

Department of Psychiatry and Psychotherapy, University of Cologne, Cologne, Germany.
Department of Neurology, University of Cologne, Cologne, Germany.

Jens Kuhn (J)

Department of Psychiatry and Psychotherapy, University of Cologne, Cologne, Germany.
Department of Psychiatry, Psychotherapy, and Psychosomatic Medicine, Johanniter Hospital Oberhausen, EVKLN, Oberhausen, Germany.

Daniel Huys (D)

Department of Psychiatry and Psychotherapy, University of Cologne, Cologne, Germany.

Veerle Visser-Vandewalle (V)

Department of Stereotaxy and Functional Neurosurgery, University Hospital Cologne, Cologne, Germany.

Thomas Foltynie (T)

Functional Neurosurgery Unit, Department of Clinical and Movement Neurosciences, University College London, Queen Square Institute of Neurology, London, UK.

Ludvic Zrinzo (L)

Functional Neurosurgery Unit, Department of Clinical and Movement Neurosciences, University College London, Queen Square Institute of Neurology, London, UK.

Marwan Hariz (M)

Functional Neurosurgery Unit, Department of Clinical and Movement Neurosciences, University College London, Queen Square Institute of Neurology, London, UK.
Department of Clinical Neuroscience, Umea University, Umea, Sweden.

Albert F G Leentjens (AFG)

Department of Psychiatry and Neuropsychology, Maastricht University Medical Center, Maastricht, The Netherlands.

Alon Y Mogilner (AY)

Center for Neuromodulation, New York University Langone Medical Center, New York, New York, USA.

Michael H Pourfar (MH)

Center for Neuromodulation, New York University Langone Medical Center, New York, New York, USA.

Leonardo Almeida (L)

Norman Fixel Institute for Neurological Diseases , Program for Movement Disorders and Neurorestoration, Departments of Neurology and Neurosurgery, University of Florida, Gainesville, Florida, USA.

Aysegul Gunduz (A)

Norman Fixel Institute for Neurological Diseases , Program for Movement Disorders and Neurorestoration, Departments of Neurology and Neurosurgery, University of Florida, Gainesville, Florida, USA.
J Crayton Pruitt Family Department of Biomedical Engineering, University of Florida, Gainesville, Florida, USA.

Kelly D Foote (KD)

Norman Fixel Institute for Neurological Diseases , Program for Movement Disorders and Neurorestoration, Departments of Neurology and Neurosurgery, University of Florida, Gainesville, Florida, USA.

Michael S Okun (MS)

Norman Fixel Institute for Neurological Diseases , Program for Movement Disorders and Neurorestoration, Departments of Neurology and Neurosurgery, University of Florida, Gainesville, Florida, USA.

Christopher R Butson (CR)

Scientific Computing and Imaging Institute, University of Utah, Salt Lake City, Utah, USA.
Department of Biomedical Engineering, University of Utah, Salt Lake City, Utah, USA.
Department of Neurosurgery, University of Utah, Salt Lake City, Utah, USA.
Departments of Neurology and Psychiatry, University of Utah, Salt Lake City, Utah, USA.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH